HC-X021

N/A

Report date: 2024/12/12 13:30:01
NME

Base Information

Drug NameHC-X021
Drug Alias NameHC-X021
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProteins inhibitors
TargetsProteins
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHinova Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHinova Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A